Invendo Medical wins CE Mark for Invendoscope SC200
Invendo Medical said today it won CE Mark approval in the European Union for its Invendoscope SC200, which it touts as the world’s 1st sterile, single-use colonoscope. The German company said its...
View ArticleMedyMatch looks to future of stroke detection with AI platform launch
Artificial intelligence healthcare startup MedyMatch Technology said late last month its AI platform designed to detect intracranial hemorrhage or brain bleeds is now available for research. The...
View Article2017 CDRH regulatory science priorities
The Center for Devices and Radiological Health (CDRH) recently issued its fiscal 2017 regulatory science priorities. The list repeats some of the points highlighted in its 2016 list, while surfacing...
View ArticleNeovasc surges on early data for Tiara mitral valve implant
Neovasc (NSDQ:NVCN) said today that early clinical data on its Tiara transcatheter mitral valve replacement showed an 86% technical success rate and 100% freedom from mild, trace or absent paravalvular...
View ArticleSanofi throws hat in the ring with J&J’s in Actelion pursuit
Sanofi (NYSE:SNY) is reportedly considering a bid for Actelion Pharmaceuticals (VTX:ATLN), competing with an offer made to the Swiss biotech by Johnson & Johnson (NYSE:JNJ). Bloomberg reported...
View ArticleMedtronic wins expanded CE Mark indication for Endurant II stent graft
Medtronic (NYSE:MDT) said today that it won an expanded CE Mark indication in the European Union for its Endurant II/IIs stent graft for treating abdominal aortic aneurysms. The expanded indication...
View ArticleEgypt arrests 45 in organ smuggling ring
(Reuters) – Egypt has uncovered a network accused of illicit international trafficking in human organs, arresting 45 people and recovering millions of dollars in a dawn raid on Tuesday, the health...
View ArticleNovo Nordisk joins Allergan in pledge to limit price hikes
Novo Nordisk (NYSE:NVO) president Jakob Riis said this week that the company will limit annual price hikes of its products’ list prices to single-digit percentages, joining Allergan (NYSE:AGN) CEO...
View ArticleEndurance through criticism: The legendary career of Dr. John Simpson
Avinger executive chairman Dr. John Simpson Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group...
View ArticleResearchers develop targeted, photodynamic nanoparticles for tumor therapy
Researchers at the University of Massachusetts Medical School have developed photodynamic nanoparticles that can effectively target deep-tissue tumors. The team’s work was published in the Journal of...
View ArticleMassDevice.com +5 | The top 5 medtech stories for December 6, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleAbyrx raises $10m, inks soft-tissue adhesive deal with Bezwada Biomedical
Abyrx said today it raised $10 million in a new equity financing round and expanded its exclusive, global license agreement with Bezwada Biomedical to include the development and production of...
View ArticleCreo Medical looks to raise $25m in UK IPO
U.K.-based electrosurgery device developer Creo Medical said today it looks to raise $25.3 million (UK £20 million) in a U.K. initial public offering, expected to take place on December 9. Creo Medical...
View ArticleNeuroEm launches study examining transcranial stim in treating Alzheimer’s
NeuroEm Therapeutics said today it launched a clinical trial testing the effect of transcranial electromagnetic treatments on patients with Alzheimer’s disease. The 2-month, phase I clinical trial aims...
View ArticleJ&J joints $7m OrthoSpace funding round
OrthoSpace said it has closed a $7 million round of equity financing, being joined by newly vested medtech giant Johnson & Johnson (NYSE:JNJ). OrthoSpace produces the InSpace orthopedic...
View ArticleChinese anti-trust regulators ding Medtronic for $17m
Chinese anti-trust regulators dinged MDT for more than $17 million for price fixing with its cardiovascular and diabetes devices. The ¥118.5 million fine levied by China’s National Development &...
View ArticleMexican regulators allow greater third party reviewer involvement for stalled...
By Stewart Eisenhart, Emergo Group COFEPRIS, Mexico’s medical device market regulator, has begun allowing Third Party Review organizations (TPRs) access to registration applications that have caused...
View ArticleBaxter releases infusion pump programming software
Baxter (NYSE:BAX) launched its Sigma Spectrum Safety Management System this week at the American Society of Health-System Pharmacists meeting. The infusion pump system consists of an analytics software...
View ArticleFDA adds high-risk indication to Abiomed’s Impella CP heart pump
Abiomed (NSDQ:ABMD) said today that it won an expanded indication from the FDA for its Impella CP heart pump for high-risk patients. The Impella CP device, which won pre-market approval earlier this...
View ArticleUK slaps Pfizer with record $107m fine over price hikes
The Competition and Markets Authority reportedly fined Pfizer (NYSE:PFE) and Flynn Pharma a record amount for the companies’ massive price hikes to its unbranded versions of the anti-epilepsy drug,...
View Article
More Pages to Explore .....